Convergence Investment Partners LLC Takes $381,000 Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Convergence Investment Partners LLC purchased a new position in Hims & Hers Health, Inc. (NYSE:HIMS) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 15,762 shares of the company’s stock, valued at approximately $381,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HIMS. CWM LLC boosted its holdings in Hims & Hers Health by 21.4% in the third quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after purchasing an additional 1,054 shares during the last quarter. Creative Planning boosted its stake in shares of Hims & Hers Health by 18.1% during the 3rd quarter. Creative Planning now owns 25,925 shares of the company’s stock valued at $478,000 after buying an additional 3,979 shares during the last quarter. Venture Visionary Partners LLC bought a new position in Hims & Hers Health during the 3rd quarter valued at $238,000. Lake Street Private Wealth LLC boosted its stake in Hims & Hers Health by 80.3% during the 3rd quarter. Lake Street Private Wealth LLC now owns 103,447 shares of the company’s stock valued at $1,905,000 after acquiring an additional 46,076 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new position in Hims & Hers Health during the 3rd quarter valued at $6,790,000. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Insider Activity

In other Hims & Hers Health news, CFO Oluyemi Okupe sold 101,993 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $29.62, for a total transaction of $3,021,032.66. Following the sale, the chief financial officer now directly owns 109,392 shares in the company, valued at approximately $3,240,191.04. The trade was a 48.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Soleil Boughton sold 2,343 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $29.90, for a total transaction of $70,055.70. Following the sale, the insider now owns 165,254 shares in the company, valued at $4,941,094.60. This trade represents a 1.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,052,332 shares of company stock valued at $32,620,497. Insiders own 17.71% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Piper Sandler increased their price target on shares of Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Canaccord Genuity Group increased their target price on Hims & Hers Health from $38.00 to $68.00 and gave the stock a “buy” rating in a report on Wednesday. Needham & Company LLC increased their target price on Hims & Hers Health from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, January 6th. TD Cowen restated a “buy” rating and set a $28.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research note on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Hims & Hers Health has a consensus rating of “Hold” and an average target price of $28.33.

Hims & Hers Health Trading Up 17.7 %

HIMS opened at $68.87 on Thursday. The business’s 50 day moving average is $33.94 and its 200-day moving average is $25.19. The stock has a market cap of $15.05 billion, a PE ratio of 156.54 and a beta of 1.35. Hims & Hers Health, Inc. has a twelve month low of $9.22 and a twelve month high of $72.98.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.